E2F5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.079770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.045400E-01
Normal-vs-Stage2
7.239700E-02
Normal-vs-Stage3
9.880500E-02
Normal-vs-Stage4
2.966200E-01
Stage1-vs-Stage2
1.281050E-01
Stage1-vs-Stage3
9.958200E-03
Stage1-vs-Stage4
4.462800E-01
Stage2-vs-Stage3
2.189200E-01
Stage2-vs-Stage4
9.848400E-01
Stage3-vs-Stage4
2.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.353800E-01
Normal-vs-AfricanAmerican
3.243800E-01
Normal-vs-Asian
9.067600E-02
Caucasian-vs-AfricanAmerican
5.516600E-01
Caucasian-vs-Asian
3.645000E-01
AfricanAmerican-vs-Asian
9.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.092400E-02
Normal-vs-Female
1.827640E-01
Male-vs-Female
3.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.549400E-01
Normal-vs-Age(41-60Yrs)
1.945790E-01
Normal-vs-Age(61-80Yrs)
8.967900E-02
Normal-vs-Age(81-100Yrs)
2.329600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.360200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.912000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.066600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.232600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.833000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.864800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.493800E-01
Normal-vs-Daily Drinker
9.810100E-02
Normal-vs-Weekly Drinker
2.678000E-02
Normal-vs-Occasional Drinker
5.518400E-01
Normal-vs-Social Drinker
4.360000E-01
Non Drinker-vs-Daily Drinker
4.365200E-01
Non Drinker-vs-Weekly Drinker
9.887800E-02
Non Drinker-vs-Occasional Drinker
4.410600E-01
Non Drinker-vs-Social Drinker
9.766600E-01
Daily Drinker-vs-Weekly Drinker
2.761600E-01
Daily Drinker-vs-Occasional Drinker
1.681180E-01
Daily Drinker-vs-Social Drinker
4.259200E-01
Weekly Drinker-vs-Occasional Drinker
3.686200E-02
Weekly Drinker-vs-Social Drinker
4.348500E-02
Occasional Drinker-vs-Social Drinker
4.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.181560E-01
Normal-vs-Grade 2
2.236500E-02
Normal-vs-Grade 3
7.370000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.793220E-01
Grade 1-vs-Grade 3
7.844400E-01
Grade 1-vs-Grade 4
1.181560E-01
Grade 2-vs-Grade 3
1.376790E-01
Grade 2-vs-Grade 4
2.236500E-02
Grade 3-vs-Grade 4
7.370000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.030200E-02
Normal-vs-NonDiabetic
1.223980E-01
Diabetic-vs-NonDiabetic
4.027400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.062780E-01
Normal-vs-NoPancreatitis
1.205610E-01
Pancreatitis-vs-NoPancreatitis
4.857000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.890580E-01
Normal-vs-N1
8.001900E-02
N0-vs-N1
4.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.834200E-01
Normal-vs-TP53-NonMutant
3.894400E-01
TP53-Mutant-vs-TP53-NonMutant
9.191800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
